Johnson & Johnson
JNJ
#23
Rank
NZ$702.88 B
Marketcap
$291.94
Share price
0.52%
Change (1 day)
13.01%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2024 (TTM): NZ$148.00 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is NZ$155.56 Billion. an increase over the revenue in the year 2023 that were of NZ$134.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2024

Annual revenue

Year Revenue Change
2024 NZ$157.49 B16.96%
2023 NZ$134.66 B-6.2%
2022 NZ$143.56 B4.57%
2021 NZ$137.29 B19.95%
2020 NZ$114.45 B-6.06%
2019 NZ$121.84 B0.18%
2018 NZ$121.62 B12.98%
2017 NZ$107.64 B3.72%
2016 NZ$103.78 B1.37%
2015 NZ$102.38 B7.92%
2014 NZ$94.86 B9.32%
2013 NZ$86.77 B6.19%
2012 NZ$81.71 B-1.93%
2011 NZ$83.32 B4.38%
2010 NZ$79.82 B-6.33%
2009 NZ$85.21 B-22.42%
2008 NZ$109.84 B37.73%
2007 NZ$79.75 B5.38%
2006 NZ$75.69 B2.42%
2005 NZ$73.90 B11.38%
2004 NZ$66.35 B3.04%
2003 NZ$64.39 B-7.15%
2002 NZ$69.35 B-11.37%
2001 NZ$78.25 B17.41%
2000 NZ$66.64 B25.18%
1999 NZ$53.24 B18.6%
1998 NZ$44.88 B15.12%
1997 NZ$38.99 B27.43%
1996 NZ$30.60 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$105.27 B-32.32%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$110.64 B-28.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$90.58 B-41.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$83.99 B-46.00%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$39.57 B-74.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$57.78 B-62.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$78.88 B-49.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$72.18 B-53.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$70.49 B-54.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$49.56 B-68.14%๐Ÿ‡บ๐Ÿ‡ธ USA